First-in-Human and Early Feasibility Study of Transcatheter Left Ventricular Myocardial Injection of Alginate Hydrogel in Heart Failure Patients – the Deke XDROP System
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - Abbott Vascular; Boston Scientific Corporation; Edwards Lifesciences; Medtronic; Corvia; V Wave
- Consultant Fee/Honoraria/Speaker's Bureau - Philips; Venus; Valgen; LagunaTech; Opus Medical